Bio-Techne (TECH) EBIT Margin (2009 - 2026)

Bio-Techne's EBIT Margin history runs 18 years deep, the most recent figure standing at 24.24% for Q1 2026.

• In Q1 2026, EBIT Margin rose 1200.0% year-over-year to 24.24%; the TTM figure through Mar 2026 stood at 12.7% (down 153.0% YoY), while the FY2025 annual figure was 8.38%, down 945.0% from the prior year.
• EBIT Margin for Q1 2026 stood at 24.24%, up from 18.41% in the prior quarter.
• The five-year high for EBIT Margin was 2815.85% in Q3 2022, with the low at 7.53% in Q2 2025.
• The 5-year median for EBIT Margin is 20.17% (2023), against an average of 183.74%.
• The sharpest annual moves came in 2022 and 2023: EBIT Margin surged 279132 bps in 2022, then sank 279568 bps in 2023.
• Bio-Techne's EBIT Margin stood at 25.0% in 2022, then sank by 44 bps to 13.94% in 2023, then climbed by 15 bps to 15.96% in 2024, then grew by 15 bps to 18.41% in 2025, then jumped by 32 bps to 24.24% in 2026.
• Business Quant data shows TECH's EBIT Margin at 24.24% in Q1 2026, 18.41% in Q4 2025, and 16.63% in Q3 2025.